These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 841999)

  • 61. [Optimization of a potentiometric technic of determining plasma fluorides: application to patients with chronic kidney failure].
    Agenet C; Combalbert I; Ragon A; Egerland A; Reynier JP
    Ann Pharm Fr; 1988; 46(1):49-54. PubMed ID: 3218835
    [No Abstract]   [Full Text] [Related]  

  • 62. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Dialysability of sulfonylurea compounds].
    Herrmann M; Kuhlmann H
    Med Welt; 1978 Sep; 29(37):1453-4. PubMed ID: 692336
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmacokinetics and dialysability of warfarin in end-stage renal disease.
    Ifudu O; Dulin AL
    Nephron; 1993; 65(1):150-1. PubMed ID: 8413775
    [No Abstract]   [Full Text] [Related]  

  • 65. Hyperglucagonaemia and renal failure.
    Matesanz R; Casado S; Valverde I; Hernando L
    Proc Eur Dial Transplant Assoc; 1977; 14():571-3. PubMed ID: 600972
    [No Abstract]   [Full Text] [Related]  

  • 66. Renal failure and the dental patient: a cautionary tale.
    Manton SL; Midda M
    Br Dent J; 1986 Jun; 160(11):388-90. PubMed ID: 2941042
    [No Abstract]   [Full Text] [Related]  

  • 67. Cell proliferation in the end-stage kidney.
    Mendley SR; Toback FG
    Am J Kidney Dis; 1990 Jul; 16(1):80-4. PubMed ID: 2195879
    [No Abstract]   [Full Text] [Related]  

  • 68. [Hemostasis in patients with chronic kidney failure treated with long-term hemodialysis].
    Opatrný K; Cepelák V; Opatrný K
    Vnitr Lek; 1988 Sep; 34(9):918-23. PubMed ID: 3201769
    [No Abstract]   [Full Text] [Related]  

  • 69. [Selection for dialysis of patients with terminal stages of chronic renal failure].
    Mel'man NIa; Peleshchuk AP; Pyrig LA; Todorenko AD; Anishchenko VM
    Vrach Delo; 1977 Jan; (1):76-80. PubMed ID: 847954
    [No Abstract]   [Full Text] [Related]  

  • 70. [The effect of long-term hemodialysis treatment on hemostasis indicators].
    Opatrný K; Cepelák V; Opatrný K; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):667-72. PubMed ID: 3739258
    [No Abstract]   [Full Text] [Related]  

  • 71. ["Dialysability" of patients in the terminal stages of chronic renal failure].
    Mel'man NIa; Peleshchuk AP; Pyrig LA; Anishchenko VM; Todorenko AD
    Vrach Delo; 1977 Jan; (1):76-80. PubMed ID: 841999
    [No Abstract]   [Full Text] [Related]  

  • 72. Hemostasis in chronic renal failure.
    Małyszko J; Małyszko JS; Myśliwiec M; Buczko W
    Rocz Akad Med Bialymst; 2005; 50():126-31. PubMed ID: 16358951
    [No Abstract]   [Full Text] [Related]  

  • 73. Oxidative metabolism of peripheral blood neutrophils in chronic renal failure on conservative and dialysis treatment.
    Luciak M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):93-5. PubMed ID: 1299177
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.